comparemela.com
Home
Live Updates
Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update : comparemela.com
Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Total 4Q and full year 2023 net product revenue of $71.5 million and $204.9 million, respectively, representing year-over-year growth of 193% and 309%
Related Keywords
New York ,
United States ,
Ottawa ,
Ontario ,
Canada ,
Canadian ,
Joe Oconnor ,
Barbara Shecter ,
Goldy Hyder ,
Darren Opland ,
Mark Jacobson ,
Herriot Tabuteau ,
Gabriel Friedman ,
World Trade Center ,
Postmedia Network Inc ,
Corporate Communications ,
Nasdaq ,
Axsome Therapeutics Inc ,
Drug Administration ,
Development Pipeline ,
National Post ,
Blackberry Ltd ,
Therapeutics Reports Fourth Quarter ,
Full Year ,
Provides Business ,
Joeo Connor ,
Victoria Wells ,
Financial Times ,
Financial Post ,
New York Times ,
Axsome Therapeutics ,
Chief Executive Officer ,
Full Year Financial ,
Postmedia Network ,
Top Stories ,
Digital Centric Commercialization ,
Breakthrough Therapy ,
Disease Agitation ,
New Drug Application ,
Deficit Hyperactivity Disorder ,
Depressive Disorder ,
Eating Disorder ,
Work Disorder ,
Trial Topline Results ,
Trial Initiations ,
Industry Minister Fran ,
Philippe Champagne ,
comparemela.com © 2020. All Rights Reserved.